Entering text into the input field will update the search result below

FDA OKs Senseonics Eversense CGM device; shares up 1%

Jun. 21, 2018 3:25 PM ETSenseonics Holdings, Inc. (SENS) StockBy: Douglas W. House, SA News Editor22 Comments
  • The FDA approves Senseonics Holdings' (NYSE:SENS +1.2%) Eversense Continuous Glucose Monitoring (CGM) System. The device features an implantable sensor that lasts up to 90 days.
  • Management will host a conference call today at 4:30 pm ET to discuss the approval and market launch plans.
  • Related tickers: (TNDM -2.2%)(DXCM -1%)(ABT -0.9%)(MDT -0.1%)(PODD -1.9%)

Recommended For You

About SENS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SENS--
Senseonics Holdings, Inc.